ArticleHealth policy and planning2019
Access to medicines through health systems in low- and middle-income countries.
Article in Health policy and planning, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
71 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Access to Essential Medicines in Low- and Middle-Income Countries: A Systematic Review of Barriers and Facilitators.International journal of public health · 2026Pooled it
- Fortifying essential medicines supply chains in Sub-Saharan Africa - the curious cases of Kenya and Uganda.Global health action · 2026Review
- Measured and perceived affordability of asthma medications and their associations with medication adherence among adult patients in Ethiopia: A cross-sectional study.Exploratory research in clinical and social pharmacy · 2026Article
- Pricing of innovative medicines and advanced therapies worldwide: an scoping review.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Pharmaceutical Wastage in Public Health Facilities of Ethiopia: Determinants, Consequences, and Solutions.Public health challenges · 2026Article
- Weak economic evidence for WHO's essential cancer medicines for Africa.BMJ global health · 2026Article
- Implementation Gaps in Public Outpatient Drug Programs: A Survey of Physicians in Urban Primary Care in Kazakhstan.International journal of environmental research and public health · 2026Article
- Health system responsiveness and its associated factors among patients with mental illness receiving outpatient care in public hospitals, Addis Ababa, Ethiopia, 2025: a facility-based cross-sectional study.BMC health services research · 2026Article
- Essential medicines out of reach: a cross-sectional study of community-level access in Eastern Uganda.BMC health services research · 2026Article
- Self-care and self-efficacy in self-care behaviors of older adults with multiple chronic conditions living in low-middle income country: an observational study.BMC nursing · 2026Article
- From informal practice to structured care: pharmaceutical indication and minor ailment management in Latin American community pharmacy.Frontiers in public health · 2026Article
- Governing access to medicines in Central America: community pharmacy, patient safety, and lessons from Spain.Frontiers in health services · 2026Article
- Design and validation of a key performance indicator dashboard for equity in community and retail pharmacy services in Pakistan.PloS one · 2026Article
- Challenges and Proposed Solutions for Optimizing the Pharmaceutical Supply Chain Using the WHO Health System Building Blocks Framework: A Systematic Review.Medical journal of the Islamic Republic of Iran · 2026Review
- Availability, affordability, and associated factors of essential medicines in primary health care facilities of the wolaita region, southern Ethiopia: implication for access, a cross-sectional study, 2022.Research in health services & regions · 2025Article
- Medicine quality assessment in Nepal using semi randomised sampling and evaluation of a small scale dissolution test and portable Raman spectrometers.Scientific reports · 2025Article
- Inequity in access to medications among communities in Eastern Ethiopia: a decomposition analysis.BMC health services research · 2025Article
- Replenish Revenue by Low-Cost Medicines, an Institution-Specific Action to Improve Access to High-Cost Medicines Used for Chronic Illness in Ethiopia: Narrative Review.Health science reports · 2025Article
- A Regional Approach to Strengthening the Implementation of Sustainable Antimicrobial Stewardship Programs in Five Countries in East, Central, and Southern Africa.Antibiotics (Basel, Switzerland) · 2025Article
- Drug utilisation research and medicine access in Mozambique: An overview.Exploratory research in clinical and social pharmacy · 2025Review
11 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nearly 2 billion people globally have no access to essential medicines. This means essential medicines are unavailable, unaffordable, inaccessible, unacceptable or of low quality for more than a quarter of the population worldwide. This supplement demonstrates the implications of poor medicine access and highlights recent innovations to improve access to essential medicines by presenting new research findings from low- and middle-income countries (LMICs). These studies answer key questions such as: Can performance-based financing improve availability of essential medicines? How affordable are cardiovascular treatments for children? Which countries' legal frameworks promote universal access to medicines? How appropriately are people using medicines? Do poor-quality medicines impact equity? Answers to these questions are important as essential medicines are vital to the Sustainable Development Goals and are central to the goal of achieving Universal Health Coverage. Access to affordable, quality-assured essential medicines is crucial to reducing the financial burden of care, preventing greater pain and suffering, shortening the duration of illness, and averting needless disabilities and deaths worldwide. This supplement was organized by the Medicines in Health Systems Thematic Working Group of Health Systems Global, a membership organization dedicated to promoting health systems research and knowledge translation. The five studies in the supplement further our understanding by showcasing recent successes and challenges of improving access to quality-assured medicines through health systems in LMICs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.